2024 ESMO Asia

Machine learning models to predict the chemotherapy induced hepatotoxicity in patients with colorectal cancer with liver metastasis

2024

AACR-KCA 2024 (American Association of Cancer Research-Korea Cancer Association)

Zolbetuximab plus chemotherapy as first-line treatment in patients with claudin 18.2 (CLDN18.2)+, HER2?, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: Korean population subgroup―combined efficacy and safety analysis from SPOTLIGHT and GLOW

2024

2024 ESMO congress

Real world efficacy of 1st-line nivolumab plus ipilimumab and its practical predictive biomarkers in advanced renal cell carcinoma: first analysis from RENOIR study [KCSG GU22-13]

2024

AACR 2024 annual meeting (American Association for Cancer Research)

Intestinal microbiome with chemotherapy response and RAS mutation in patients with advanced or metastatic colorectal cancer: a pilot, exploratory study

2024

ESMO Asia congress 2023

Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer from K-MASTER project

2023